Haematology and Immunoglobulin Treatments      

FOI REFERENCE: 24502     FOI DATE: 7^th November 2024      

Q1. In the past 3 months, how many patients have received the following treatments (for any disease): 

·       Berinert (Human C1-esterase inhibitor)  1

·       Cinryze (Human C1-esterase inhibitor)  0

·       Firazyr (Icatibant) 0

·       Icatibant – any brand except Firazyr 0                    

·       Orladeyo (Berotralstat) 0

·       Ruconest (Recombinant human C1-esterase inhibitor) 0  

·       Takhzyro (Lanadelumab) 0

Q2. In the past 3 months, how many patients have received the following immunoglobulin treatments (for any disease): 

·       Cutaquig 0

·       Cuvitru 0

·       Gammagard 0

·       Gammanorm 0

·       Hizentra 0

·       Hyqvia 0

·       Intratect 18

·       Iqymune 0

·       Kiovig 0

·       Privigen 19

·       Octagam 3                    

·       Panzyga 0

·       Subgam 0

·       Any other normal immunoglobulin 7 (FlebogammaDif)